SCHEMBL30906837

SCHEMBL30906837

CC(O)c1sc(-c2nc(NC3CCN(S(=O)(=O)c4cnn(C)c4)CC3)ncc2C(F)(F)F)cc1C#N

nearest known ligand 0.57

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ CDK2 P24941 20/20 0.57
▸ CCNE1 P24864 19/20 0.57
▸ CCND1 P24385 14/20 0.57
▸ CDK6 Q00534 14/20 0.57
▸ CDK1 P06493 13/20 0.57
▸ CCNB1 P14635 13/20 0.57
▸ CDK4 P11802 12/20 0.57
▸ CCND3 P30281 12/20 0.57
▸ CCNT1 O60563 7/20 0.57
▸ CDK7 P50613 7/20 0.57
▸ CDK9 P50750 7/20 0.57
▸ CCNH P51946 7/20 0.57
▸ MNAT1 P51948 7/20 0.57
▸ CCNK O75909 1/20 0.41
▸ CCNA2 P20248 1/20 0.41
▸ CDK12 Q9NYV4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27213171 1.00 CDK2 (0.57) CDK2CCNE1CCND1CDK6CDK1
SCHEMBL30906786 0.90 CCNE1 (0.47) CDK2CCNE1CCND1CDK6CDK1
SCHEMBL27213236 0.90 CCNE1 (0.47) CDK2CCNE1CCND1CDK6CDK1
SCHEMBL27213208 0.90 CCNE1 (0.47) CDK2CCNE1CCND1CDK6CDK1
SCHEMBL30906830 0.90 CCNE1 (0.47) CDK2CCNE1CCND1CDK6CDK1
SCHEMBL30906794 0.89 CDK2 (0.61) CDK2CCNE1CCND1CDK6CDK1
SCHEMBL27213203 0.89 CDK2 (0.61) CDK2CCNE1CCND1CDK6CDK1
SCHEMBL30906882 0.89 CCNE1 (0.58) CDK2CCNE1CCND1CDK6CDK1
SCHEMBL27213199 0.89 CCNE1 (0.58) CDK2CCNE1CCND1CDK6CDK1
SCHEMBL30906821 0.88 CCNE1 (0.57) CDK2CCNE1CCND1CDK6CDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024077216-A1 CDK INHIBITORS AND THEIR USE AS PHARMACEUTICALS PRELUDE THERAPEUTICS INCORPORATED (US) 2024-04-11 — — WO claimed
WO-2024077216-A1 CDK INHIBITORS AND THEIR USE AS PHARMACEUTICALS PRELUDE THERAPEUTICS INCORPORATED (US) 2024-04-11 — — WO disclosed
Send feedback